SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-006455
Filing Date
2024-05-02
Accepted
2024-05-02 07:47:23
Documents
16
Period of Report
2024-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K elev-20240502x8k.htm   iXBRL 8-K 42551
2 EX-99.1 elev-20240502xex99d1.htm EX-99.1 84161
  Complete submission text file 0001558370-24-006455.txt   268669

Data Files

Seq Description Document Type Size
3 EX-101.SCH elev-20240502.xsd EX-101.SCH 3909
4 EX-101.DEF elev-20240502_def.xml EX-101.DEF 2818
5 EX-101.LAB elev-20240502_lab.xml EX-101.LAB 17905
6 EX-101.PRE elev-20240502_pre.xml EX-101.PRE 11882
19 EXTRACTED XBRL INSTANCE DOCUMENT elev-20240502x8k_htm.xml XML 4990
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 24905347
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)